Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Kodiak Sciences Inc
IPO Date: October 1, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $555.68M
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.05 | 3.71%
Avg Daily Range (30 D): $0.53 | 6.25%
Avg Daily Range (90 D): $0.32 | 5.42%
Institutional Daily Volume
Avg Daily Volume: .43M
Avg Daily Volume (30 D): .6M
Avg Daily Volume (90 D): .43M
Trade Size
Avg Trade Size (Sh.): 88
Avg Trade Size (Sh.) (30 D): 88
Avg Trade Size (Sh.) (90 D): 93
Institutional Trades
Total Inst.Trades: 1,226
Avg Inst. Trade: $2.34M
Avg Inst. Trade (30 D): $.81M
Avg Inst. Trade (90 D): $.83M
Avg Inst. Trade Volume: .06M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.8M
Avg Closing Trade (30 D): $.85M
Avg Closing Trade (90 D): $.85M
Avg Closing Volume: 59.71K
   
News
Jan 10, 2025 @ 2:35 PM
Diabetic Retinopathy Global Clinical Trials Review...
Source: Researchandmarkets.Com
Jun 20, 2024 @ 12:23 PM
Should You Hold Kodiak Sciences (KOD) Stock in You...
Source: Zacks Equity Research
Jun 14, 2024 @ 3:30 PM
Why Is Kodiak Sciences (KOD) Down 26.2% Since Last...
Source: Zacks Equity Research
May 16, 2024 @ 4:51 PM
Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipel...
Source: Zacks Equity Research
Apr 4, 2024 @ 4:09 PM
Kodiak (KOD) Counts on Tarcocimab Program Despite ...
Source: Zacks Equity Research
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-3.63 $-1.09 $-.84
Diluted EPS $-3.63 $-1.09 $-.84
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -190.63M $ -57.46M $ -44.11M
Operating Income / Loss $ -199.87M $ -59.07M $ -46.18M
Cost of Revenue $ $ $
Net Cash Flow $ -107.07M $ -29.22M $ -29.79M
PE Ratio